News

Congratulations to Ilya and Daria and we wish you easy implementation of your projects!

The book is called "The Birth of the Patient: Multiple Entities of Newborns in Russian Neonatal Care". Analyzing documents, semi-structured as well as expert interviews with healthcare professionals, focus groups and employing participant observation and self-observation methodologies, Anastasia Novkunskaya , Artemy Minakov and Anna Klepikova examine the structure of the neonatal care system using the example of one of the Russian regions.

An updated chapter of the International Encyclopedia of Public Health has been published. Co-authored Anton Barchuk, director of EUSP’s Institute for Interdisciplinary Medical Research, the chapter is devoted to cancer screening.

On October 18, a scientific article was published in the journal BMC Cancer, in which researchers from the Institute of Medical Studies of the European University at St. Petersburg and the N.N. Petrov National Medical Research Center of Oncology assessed the completeness of the data from cancer registries in the regions of the Northwestern Federal District for 2008–2017.

The expert will speak at the session “How women are fighting for their rights and social opportunities, from the capital to small towns”.

Researchers from the European University and the Sergey Berezin Medical Institute (MIBS) have calculated the effectiveness of Russian vaccines against lung damage during COVID-19 waves caused by  the Delta and Omicron strains. The effectiveness of two doses of Sputnik V was 56%. The effectiveness of three doses was 71%.  EpiVacCorona was not shown to be effective. 

Researchers from the European University at St. Petersburg and the Medical Institute named after Berezin Sergey (MIBS) calculated the effectiveness of Russian vaccines against symptomatic coronavirus infection during an outbreak caused by the delta variant. "Sputnik V" protects against the delta variant. Тhe effectiveness of the vaccine was 58%. In reality, the efficacy is even higher, since this calculated figure is influenced by the number of people who recovered but were not included in the data.

According to the results of the new stage of a serological survey, more than 80% of adults in St. Petersburg have antibodies to SARS-CoV-2. Repeat infections (confirmed by PCR tests) are relatively rare events-under 3%. In order for the active phase of the epidemic to end, as many citizens as possible must have immune protection.

The journal Science of the American Association for the Advancement of Science published an article about an independent study of the effectiveness of vaccination, which was conducted by scientists from the European University, the Medical Institute named after Sergey Berezin, the First honey in St. Petersburg and the Tarus Hospital.

Vaccinated residents of St. Petersburg with symptomatic COVID-19 are almost 5 times less likely to have severe disease. Vaccine effectiveness against hospitalization was 81% for fully vaccinated individuals.

Now Covid-19 cases are rising and the government is trying to convince hesitant residents to get a vaccine.

The July 1 webinar on COVID-19 vaccination “Hey, are you vaccinated?” featuring professors from Skoltech, the European University in Saint Petersburg and New Economic School attracted over a hundred pressing questions on SARS-CoV-2 and the vaccines against it.